300878.SZ · 维康药业
China A-shares · RS rating 54 · As of 2026-10-14
| Price | 28.39 CNY |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 54 / 13 / 27 / 85 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 39 / 8 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -18.9% |
| Distance from 52-week high | +28.0% |
| Market cap (USD) | $647.4M |